Reduction Of Disease Burden On Workplace and Household Productivity In Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis, Over 48 Weeks Of Treatment With Certolizumab Pegol

被引：0
|
作者：
van der Heijde, Desiree M. [1 ]
Braun, Juergen [2 ]
Rudwaleit, Martin [3 ]
Purcaru, Oana [4 ]
Kavanaugh, Arthur [5 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Rheumazentrum Ruhrgebiet, Herne, Germany
[3] Endokrinologikum Berlin, Berlin, Germany
[4] UCB Pharma, Brussels, Belgium
[5] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
WORK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1520
引用
收藏
页码：S644 / S645
页数：2
相关论文
共 50 条
  • [1] Effect Of Certolizumab Pegol Over 48 Weeks In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Landewe, Robert B. M.
    Rudwaleit, Martin
    van der Heijde, Desiree M.
    Dougados, Maxime
    Mease, Philip J.
    Reveille, John D.
    Walsh, Jessica
    Kivitz, Alan J.
    Maksymowych, Walter P.
    Braun, Juergen
    Deodhar, Atul A.
    Stach, Christian
    Hoepken, Bengt
    Singh, Pritibha
    Sieper, Joachim
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S767 - S767
  • [2] Effect of Certolizumab Pegol Over 48 Weeks in Patients with Axial Spondyloarthritis, including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Maksymowych, Walter
    Landewe, Robert
    Rudwaleit, Martin
    van der Heijde, Desiree
    Dougados, Maxime
    Mease, Phillip
    Reveille, John
    Walsh, Jessica
    Kivitz, Alan
    Braun, Juergen
    Deodhar, Atul
    Stach, Christian
    Hoepken, Bengt
    Singh, Pritibha
    Sieper, Joachim
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1496 - 1497
  • [3] SUSTAINED IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION WITH CERTOLIZUMAB PEGOL OVER 96 WEEKS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
    van der Heijde, D.
    Braun, J.
    Rudwaleit, M.
    Purcaru, O.
    Kavanaugh, A.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A387 - A387
  • [4] Sustained Improvements in Workplace and Household Productivity and Social Participation with Certolizumab Pegol over 96 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis.
    van der Heijde, Desiree
    Braun, Juergen
    Rudwaleit, Martin
    Purcaru, Oana
    Kavanaugh, Arthur
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1119 - S1119
  • [5] Safety and Efficacy of Certolizumab Pegol over 204 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Deodhar, Atul A.
    Dougados, Maxime
    Landewe, Robert
    Sieper, Joachim
    Maksymowych, Walter
    Rudwaleit, Martin
    van Den Bosch, Filip
    Braun, Juergen
    Mease, Philip J.
    Kivitz, Alan
    Walsh, Jessica
    Davies, Owen
    Hoepken, Bengt
    Peterson, Luke
    van der Heijde, Desiree
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] Safety and Efficacy of Certolizumab Pegol over 96 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis.
    Sieper, Joachim
    Rudwaleit, Martin
    van der Heijde, Desiree M.
    Maksymowych, Walter P.
    Dougados, Maxime
    Mease, Philip
    Braun, Juergen
    Deodhar, Atul A.
    Hoepken, Bengt
    Nurminen, Tommi
    Landewe, Robert B. M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S376 - S377
  • [7] LONG-TERM IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION OVER 4 YEARS OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
    van der Heijde, D.
    Braun, J.
    Rudwaleit, M.
    Landewe, R.
    Purcaru, O.
    Kavanaugh, A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A546 - A546
  • [8] LONG-TERM IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION OVER 4 YEARS OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
    van der Heijde, D.
    Braun, J.
    Rudwaleit, M.
    Landewe, R.
    Purcaru, O.
    Kavanaugh, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 809 - 809
  • [9] CONTINUED IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY WITH CERTOLIZUMAB PEGOL TREATMENT IN AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 48-WEEK RESULTS FROM THE RAPID-AXSPA STUDY
    van der Heijde, D.
    Braun, J.
    Rudwaleit, M.
    Purcaru, O.
    Kavanaugh, A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A570 - A570
  • [10] Four Year Imaging Outcomes in Patients with Axial Spondyloarthritis Treated with Certolizumab Pegol, Including Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    van der Heijde, Desiree
    Baraliakos, Xenofon
    Hermann, Kay-Geert
    Landewe, Robert
    Machado, Pedro
    Maksymowych, Walter
    Davies, Owen
    de Peyrecave, Natasha
    Hoepken, Bengt
    Bauer, Lars
    Nurminen, Tommi
    Braun, Juergen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345